Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.7350
-0.0200 (-2.65%)
At close: Apr 1, 2025, 4:00 PM
0.7632
+0.0282 (3.84%)
After-hours: Apr 1, 2025, 4:47 PM EDT
Adicet Bio Stock Forecast
ACET's stock price has decreased by -68.72% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Adicet Bio stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 716.33% from the current stock price of 0.74.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Adicet Bio stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 5 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +852.38% | Mar 21, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 27, 2025 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 6, 2025 |
Financial Forecast
Revenue This Year
4.08M
Revenue Next Year
4.08M
from 4.08M
EPS This Year
-1.30
from -1.33
EPS Next Year
-0.92
from -1.30
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 21.0M | 21.0M | 179.7M | ||
Avg | 4.1M | 4.1M | 35.2M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 414.7% | 4,304.2% | ||
Avg | - | - | 761.9% | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.04 | -0.77 | -0.48 | ||
Avg | -1.30 | -0.92 | -0.83 | ||
Low | -1.47 | -1.11 | -1.08 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.